Lineage Cell Therapeutics
LCTX
LCTX
66 hedge funds and large institutions have $98.9M invested in Lineage Cell Therapeutics in 2016 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 20 increasing their positions, 19 reducing their positions, and 5 closing their positions.
Holders
66
Holders Change
-2
Holders Change %
-2.94%
% of All Funds
1.76%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
5
Increased
20
Reduced
19
Closed
5
Calls
–
Puts
$874K
Net Calls
-$874K
Net Calls Change
+$388K
Top Buyers
1 |
BC
1
Broadwood Capital
New York
|
$63.6M |
2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$5.79M |
3 |
3
Jane Street
New York
|
$229K |
4 |
4
State Street
Boston,
Massachusetts
|
$2.26M |
5 |
BG
5
BlackRock Group
London,
United Kingdom
|
$108K |